Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget's disease of bone

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 6, 2008, Pages 635-641

  Avramidis, Avraam ^a   Polyzos, Stergios A ^a   Moralidis, Efstratios ^b   Arsos, Georgios ^b   Efstathiadou, Zoe ^a   Karakatsanis, Konstantinos ^b   Grollios, Georgios ^a   Kita, Marina ^a  

^a Aristotle University of Thessaloniki   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Alkaline phosphatase; Bisphosphonate; Paget's disease; Scintigraphy; Zoledronic acid

Indexed keywords

ALKALINE PHOSPHATASE; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; IMIDAZOLE DERIVATIVE;

ADULT; ARTICLE; BONE SCINTISCANNING; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PAGET BONE DISEASE; PRIORITY JOURNAL; TREATMENT RESPONSE; AGED; BONE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING;

EID: 58149235544     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-008-0852-6     Document Type: Article

References (34)

1. P.L. Selby M.W. Davie S.H. Ralston M.D. Stone 2002 Guidelines on the management of Paget's disease of bone Bone (NY) 31 366 373
2. S. Takata J. Hashimoto K. Nakatsuka N. Yoshimura K. Yoh I. Ohno H. Yabe S. Abe M. Fukunaga M. Terada M. Zamma S.H. Ralston H. Morii H. Yoshikawa 2006 Guidelines for diagnosis and management of Paget's disease of bone in Japan J Bone Miner Metab 24 359 367
3. C. Cooper N.C. Harvey E.M. Dennison T.P. van Staa 2006 Update on the epidemiology of Paget's disease of bone J Bone Miner Res 21 suppl2 3 8
4. L. Gennari D. Merlotti G. Martini R. Nuti 2006 Paget's disease of bone in Italy J Bone Miner Res 21 suppl2 14 21
5. P.L. Selby 2006 Guidelines for the diagnosis and management of Paget's disease: a UK perspective J Bone Miner Res 21 suppl2 92 93
6. D. Hosking K. Lyles J.P. Brown W.D. Fraser P. Miller M.D. Curiel J.P. Devogelaer M. Hooper G. Su K. Zelenakas J. Pak T. Fashola Y. Saidi E.F. Eriksen I.R. Reid 2007 Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate J Bone Miner Res 22 142 148
7. I.R. Reid P. Miller K. Lyles W. Fraser J.P. Brown Y. Saidi P. Mesenbrink G. Su J. Pak K. Zelenakas M. Luchi P. Richardson D. Hosking 2005 Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease N Engl J Med 353 898 908
8. I.R. Reid 2006 Zoledronate: efficacy and safety J Bone Miner Res 21 suppl2 83 87
9. E.S. Siris K.W. Lyles F.R. Singer P.J. Meunier 2006 Medical management of Paget's disease of bone: indications for treatment and review of current therapies J Bone Miner Res 21 suppl2 94 98
10. G.M. Keating L.J. Scott 2007 Zoledronic acid: a review of its use in the treatment of Paget's disease of bone Drugs 67 793 804
11. G.H. Nancollas R. Tang R.J. Phipps Z. Henneman S. Gulde W. Wu A. Mangood R.G. Russell F.H. Ebetino 2006 Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite Bone (NY) 38 617 627
12. J.E. Dunford K. Thompson F.P. Coxon S.P. Luckman F.M. Hahn C.D. Poulter F.H. Ebetino M.J. Rogers 2001 Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates J Pharmacol Exp Ther 296 235 242
13. J. Shapiro B. Smith T. Beck P. Ballard M. Dapthary K. BrintzenhofeSzoc J. Caminis 2007 Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury Calcif Tissue Int 80 316 322
14. K. Tziomalos M. Florentin N. Krikis V. Perifanis A. Karagiannis F. Harsoulis 2007 Persistent effect of zoledronic acid in Paget's disease Clin Exp Rheumatol 25 464 466
15. 99mTc-methylene diphosphonate bone scanning J Nucl Med 42 1359 1363
16. U. Patel S.J. Gallacher I.T. Boyle J.H. McKillop 1990 Serial bone scans in Paget's disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment Nucl Med Commun 11 747 760
17. C.J. Vellenga E.K. Pauwels O.L. Bijvoet H.I. Harinck W.B. Frijlink 1985 Quantitative bone scintigraphy in Paget's disease treated with APD Br J Radiol 58 1165 1172
18. F. Pons L. Alvarez P. Peris N. Guanabens S. Vidal-Sicart A. Monegal J. Pavia A.M. Ballesta J. Munos-Gomez R. Herranz 1999 Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity Nucl Med Commun 20 525 528
19. J.P. Lavender I.M. Evans R. Arnot S. Bowring F.H. Doyle G.F. Joplin I. MacIntyre 1977 A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin Br J Radiol 50 243 250
20. 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment Radiology 125 761 764
21. B.C. Lentle A.S. Russell P.G. Heslip J.S. Percy 1976 The scintigraphic findings in Paget's disease of bone Clin Radiol 27 129 135
22. M. Rashid A. Khairi C. Johnston Jr 1977 Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP) Clin Orthop Relat Res 127 94 105
23. G. Ang D. Feiglin A.M. Moses 2003 Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels Endocr Pract 9 280 283
24. P.J. Ryan T. Gibson I. Fogelman 1992 Bone scintigraphy following intravenous pamidronate for Paget's disease of bone J Nucl Med 33 1589 1593
25. I.R. Reid J.S. Davidson D. Wattie F. Wu J. Lucas G.D. Gamble M.D. Rutland T. Cundy 2004 Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone Bone (NY) 35 224 230
26. I. Fogelman D. Carr I.T. Boyle 1981 The role of bone scanning in Paget's disease Metab Bone Dis Relat Res 3 243 254
27. C.J. Vellenga O.L. Bijvoet E.K. Pauwels 1988 Bone scintigraphy and radiology in Paget's disease of bone: a review Am J Physiol Imaging 3 154 168
28. A. Avramides A. Flores J. DeRose S. Wallach 1976 Paget's disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment J Clin Endocrinol Metab 42 459 463
29. S.E. Papapoulos E.M. Eekhoff A.H. Zwinderman 2006 Acquired resistance to bisphosphonates in Paget's disease of bone J Bone Miner Res 21 suppl2 88 91
30. D. Merlotti L. Gennari G. Martini F. Valleggi P.V. De A. Avanzati R. Nuti 2007 Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone J Bone Miner Res 22 1510 1517
31. S.C. Cremers M.E. Eekhoff H.J. Den N.A. Hamdy P. Vermeij S.E. Papapoulos 2003 Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget's disease of bone J Bone Miner Res 18 868 875
32. M.D. Stone D.H. Marshall D.J. Hosking A.C. Perkins A.J. Evans M.L. Wastie 1992 Bisphosphonate space measurement in Paget's disease of bone treated with APD J Bone Miner Res 7 295 301
33. H. Fleisch 1998 Bisphosphonates: mechanisms of action Endocr Rev 19 80 100
34. K.L. Kavanagh K. Guo J.E. Dunford X. Wu S. Knapp F.H. Ebetino M.J. Rogers R.G. Russell U. Oppermann 2006 The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs Proc Natl Acad Sci U S A 103 7829 7834